NCT03976141已完成不适用
Validation of a New Topographic Classification of Bone Marrow Lesions of the Knee
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- The researchers will calculate the prevalence of BMLs in knee MRI and calculate the intra-observer and inter-observer reliability of the new classification proposed.
研究概览
简要总结
the investigator are studying a new topographic classification of bone marrow lesion in the knee and validating it.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age over 18 with mri with lesion consent given
排除标准
- •under mri previous surgery tumors no consent
结局指标
主要结局
The researchers will calculate the prevalence of BMLs in knee MRI and calculate the intra-observer and inter-observer reliability of the new classification proposed.
时间窗: The lesions will be evaluated on knee MRI performed in the period between January 2017 to December 2018
This study proposes a topographic classification for knee BMLs consisting in 5 different types of lesions. the classification proposed will be validated by 3 independent researchers.
次要结局
未报告次要终点
研究者
Pietro Randelli, MD
Professor
University of Milan
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn DiseaseCrohn DiseaseInflammatory Bowel DiseaseNCT04508088Massachusetts General Hospital92
已完成
不适用
Standing Computed Tomography (SCT) Imaging of the Knee JointOsteoarthritis, KneeNCT03446404Neil A Segal826
已完成
不适用
7T MRI to Evaluate Cartilage Defects in the KneeCartilage InjuryKnee InjuriesArthropathy of KneeCartilage DamageKnee Pain SwellingNCT04118023The Methodist Hospital Research Institute112
已完成
不适用
In Vivo Three-Dimensional Determination of Osteoarthritis Brace EffectivenessOsteoarthritis, KneeNCT04111276The University of Tennessee, Knoxville23
已完成
4 期
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate CancerProstate CancerNCT00391690Novartis99